Skip to content
Artwork for The Tox Lab

The Tox Lab

The Tox Lab

The Tox Lab is a podcast dedicated to exploring the science of toxicology and its real-world implications. Each week we aim to break down complex research, investigate real-life cases, and discuss emerging trends in toxicology.

Disclaimer: All opinions are our own.

Find us on instagram: @the_tox_lab
Email us here: thetoxlab@gmail.com

Play
  • 31 episodes
  • weekly
  • Avg 28 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E82
    June 22 · 28 min

    Episode 82: Gabapentin and Pregabalin – Effectiveness, Trends and Toxicity

    This week on The Tox Lab, we’re discussing gabapentinoids and examining the use, effectiveness, and toxicological considerations surrounding gabapentin and pregabalin. Originally developed as anti-epileptic medications, gabapentinoids have become widely used for the treatment of neuropathic pain and a range of other conditions. We begin by examining prescribing trends and discussing the evidence surrounding their effectiveness, including whether these drugs are as beneficial as once thought in all patient groups. We then explore some of the adverse effects associated with gabapentinoids and discuss the risks associated with their use alongside other central nervous system depressants, including opioids and benzodiazepines. Finally, we turn to the forensic and toxicological aspects of gabapentinoid use, examining their involvement in driving under the influence of drugs cases and post-mortem investigations. We discuss what these findings tell us about the increasing prevalence of gabapentinoids and their role in drug-related deaths. Join us as we examine the benefits, limitations, and toxicological considerations surrounding gabapentin and pregabalin, and consider what their growing use means for patients and healthcare systems. Hope you enjoy! Links to the papers we discussed: https://pmc.ncbi.nlm.nih.gov/articles/PMC11626918/ https://shmpublications.onlinelibrary.wiley.com/doi/full/10.1002/jhm.70286 https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkag040/8703238?redirectedFrom=fulltext https://www.sciencedirect.com/science/article/pii/S037907382100150X?via%3Dihub Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Check out our new website: https://thetoxlab.co.uk/ Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E81
    June 15 · 26 min

    Episode 81: Alexander Shulgin – The Man Who Shaped Modern Psychedelics

    This week on The Tox Lab, we’re discussing the life and work of one of the most influential figures in psychedelic chemistry, Alexander “Sasha” Shulgin. From his early career at Dow Chemical to his pioneering work with psychoactive compounds, Shulgin’s career helped shape the modern landscape of psychedelic research. We discuss his fascination with psychedelics, his meticulous approach to self-experimentation, and his synthesis and investigation of hundreds of compounds, including his role in the rediscovery of MDMA and the publication of PIHKAL and TIHKAL. Join us as we examine the science, stories, and controversies surrounding Alexander Shulgin, and consider how one chemist helped shape our modern understanding of psychedelic drugs. Link to Shulgin's laboratory notebooks: https://www.erowid.org/library/books_online/shulgin_labbooks/ Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Check out our new website: https://thetoxlab.co.uk/ Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E80
    June 1 · 36 min

    Episode 80: Novel Benzodiazepines – Emerging Trends and Analytical Challenges

    This week on The Tox Lab, we’re discussing novel benzodiazepines and examining recent trends in their emergence and detection. We begin by exploring the origins of novel benzodiazepines, including how these compounds have entered the drug market and the factors contributing to their continued appearance. We then turn to a paper from the Society of Forensic Toxicologists (SOFT) Novel Psychoactive Substances Committee, examining trends in novel benzodiazepine detections between 2021 and 2025. We discuss findings from post-mortem investigations, clinical presentations, driving under the influence of drugs cases, and drug-facilitated crime, highlighting the compounds most commonly encountered, including bromazolam, etizolam, and desalkylgidazepam, and how patterns have changed over time. We also explore the analytical challenges associated with novel benzodiazepines, including their detection and identification in toxicology laboratories, the limitations of routine testing, and the difficulties associated with interpreting toxicological findings when limited pharmacological, toxicological, and concentration data are available. Join us as we examine the evolving landscape of novel benzodiazepines, consider the challenges they present for forensic and clinical toxicology, and discuss what these trends may tell us about the future of the drug market. Hope you enjoy! Links to the paper we discussed: https://academic.oup.com/jat/advance-article/doi/10.1093/jat/bkag026/8662327?searchresult=1 https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkag027/8663758?redirectedFrom=fulltext Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Check out our new website: https://thetoxlab.co.uk/ Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E79
    May 25 · 25 min

    Episode 79: Kava – Tradition, Benefits and Toxicity

    This week on The Tox Lab, we’re discussing kava and examining its history, use, and potential toxicological effects. We begin by exploring the history of kava and its longstanding cultural and social significance, before discussing reported benefits associated with its use and the reasons it continues to gain popularity. We then turn to potential harms associated with kava, examining cases of acute liver injury and acute interstitial nephritis linked to its use, before discussing a fatal case involving kava ingestion and the toxicological considerations surrounding these reports. Join us as we examine the evolving story surrounding kava, from its traditional use and perceived benefits to the clinical and toxicological challenges associated with its increasing use. Links to the papers we discussed: https://pmc.ncbi.nlm.nih.gov/articles/PMC12405834/pdf/DAR-44-1601.pdf https://doi.org/10.1155/crgm/3914876 https://onlinelibrary.wiley.com/doi/10.1111/nep.70051 http://dx.doi.org/10.1016/j.forsciint.2015.01.032 Check out our new website: https://thetoxlab.co.uk/ Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E78
    May 18 · 19 min

    Episode 78: Strange Things in Strange Places – Poison Dart Frogs, Navalny and Epibatidine

    This week on The Tox Lab, we’re discussing poison dart frogs and the alkaloid epibatidine. We begin by examining recent reports surrounding the death of Alexei Navalny and the suggestion that epibatidine may have been involved. We then discuss poison dart frogs and the toxins found within them, including the discovery and isolation of epibatidine. From there, we explore its potent analgesic properties, how it acts at nicotinic acetylcholine receptors, and what makes it both pharmacologically interesting and highly toxic. Finally, we examine attempts to develop epibatidine analogues as novel analgesics and explore the evolutionary question of how poison dart frogs themselves avoid poisoning. Join us as we examine the pharmacology, toxicity, and evolving story surrounding epibatidine, and consider how a toxin derived from poison dart frogs became linked to drug development, toxicology, and international headlines. Hope you enjoy! Links to the papers we discussed: https://www.gov.uk/government/news/joint-statement-by-the-uk-sweden-france-germany-and-the-netherlands-on-alexei-navalnys-death https://pubs.rsc.org/en/content/articlelanding/2000/np/a900728h https://www.science.org/doi/epdf/10.1126/science.aan5061 Check out our new website: https://thetoxlab.co.uk/ Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E77
    May 11 · 21 min

    Episode 77: Novel Synthetic Opioids – An Update on Emerging Trends

    This week on The Tox Lab, we’re back with a long-awaited update on novel synthetic opioids. We begin by discussing the April 2026 UNODC announcement on the increasingly varied forms in which synthetic opioids are being encountered, including vapes, powders, and counterfeit tablets marketed as benzodiazepines, oxycodone, and MDMA. We then turn to the emergence of orphine analogues in both the UK and the US, discussing recent reports and trends associated with these compounds. Finally, we examine a clinical case involving N-propionitrile chlorphine (cychlorphine), exploring the toxicological features and the challenges these emerging opioids present for clinicians, laboratories, and public health systems. Join us as we examine the changing landscape of novel synthetic opioids, consider what these developments may mean for toxicology, harm reduction, and public health, and discuss where the market may be heading next. Hope you enjoy! This episode is very kindly sponsored by Cayman Chemical. Check out their Synthetic Opioid Analytical Standards Panel here: https://www.caymanchem.com/product/44436/synthetic-opioid-analytical-standards-panel-1 Links to papers we discussed: https://www.unodc.org/LSS/Announcement/Details/973e194e-f8d6-4b4e-8aca-166aaec4ac7c https://www.polizei.bayern.de/aktuelles/pressemitteilungen/100413/index.html https://onlinelibrary.wiley.com/doi/10.1111/dar.70081 https://assets.publishing.service.gov.uk/media/69f3343fab602a88957eef2b/Seventh_addendum_to_the_ACMD_report_on_the_use_and_harms_of_2-benzyl-benzimidazole__nitazene__and_piperidine_benzimidazolone__brorphine-like__opioids_FINAL.pdf https://www.cfsre.org/nps-discovery/public-alerts/increase-in-fatal-overdoses-linked-to-novel-synthetic-opioid-n-propionitrile-chlorphine-cychlorphine https://www.tandfonline.com/doi/full/10.1080/15563650.2025.2594070 Link to our paper on N-pyrrolidino Isotonitazene: https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkag027/8663758?redirectedFrom=fulltext Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E76
    May 4 · 24 min

    Episode 76: Naloxone - Access, Harm Reduction and Disparities

    This week on The Tox Lab, we are taking a look at the role of naloxone in risk taking behaviours, harm reduction and disparities surrounding naloxone access. We begin by discussing a study looking at the expansion of naloxone access laws in the United States, exploring whether increased availability is associated with changes in heroin use among adolescents. We then turn to a commentary paper examining the benefits and limitations of educating school children recognise an opioid overdose and administer naloxone. Finally we discuss a paper investigating disparities in naloxone uptake amongst different ethnic and racial groups, and between individuals who inject versus smoke substances. Join us as we explore the impact of naloxone access, education, and disparities, and consider what these findings mean for harm reduction and public health. Hope you enjoy! Links to the papers we discussed: https://www.sciencedirect.com/science/article/abs/pii/S0955395923000294 https://onlinelibrary.wiley.com/doi/abs/10.1111/josh.70089 https://pubmed.ncbi.nlm.nih.gov/41428846/ Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E75
    April 27 · 26 min

    Episode 75: Kratom Is Changing - New Semi-Synthetic Compounds & Rising Harm

    A year after we first took a look at mitragynine (kratom), we are back with an update episode looking at how the landscape surrounding mitragynine is evolving. We begin by examining poison centre data, exploring trends in reported exposures in the US and internationally, and the increase in its use. We then discuss a case involving semi-synthetic mitragynine derivatives, including 7-hydroxymitragynine and mitragynine pseudoindoxyl, highlighting the clinical features including dose escalation, and challenges associated with withdrawal. Finally, we turn to reports of combined use of kratom and kava, and consider how this may influence toxicity and withdrawal. Join us as we examine emerging data, evolving patterns of use, and the clinical implications of mitragynine and its derivatives, and consider what these findings mean for toxicology and public health. Hope you enjoy! If you'd like us to cover an episode on Kava, please let us know in the comments! Links to the papers we discussed: https://www.cdc.gov/mmwr/volumes/75/wr/mm7511a1.htm https://www.cureus.com/articles/467977-severe-early-onset-withdrawal-following-intentional-use-of-mitragynine-pseudoindoxyl-a-case-report-and-emerging-clinical-considerations#!/ https://www.cdc.gov/mmwr/volumes/75/wr/pdfs/mm7512a1-H.pdf https://journals.lww.com/journaladdictionmedicine/abstract/9900/kava_potentiated_withdrawal_in_persons_using.687.aspx Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • S1 · E74
    April 20 · 18 min

    Episode 74: Codeine – Pharmacogenetics, Breastfeeding and the 2006 Lancet Case

    This week on The Tox Lab, we’re examining the controversial 2006 Lancet paper on codeine and fatal opioid toxicity in a breastfed infant. We begin by introducing the paper and the case at its centre, in which an infant developed fatal opioid toxicity following exposure to codeine via breast milk. We then explore the proposed mechanism, focusing on the role of CYP2D6 metabolism and how variability in this pathway may lead to higher-than-expected morphine concentrations. We also discuss the limitations and criticisms of the paper, including questions around causality, alternative explanations, and the extent to which pharmacogenetics alone can account for the outcome. Finally, we consider the wider impact of this publication, including changes to clinical guidance, prescribing practices, and the ongoing debate around codeine use in breastfeeding individuals. Join us as we examine the pharmacology, pharmacogenetics, and controversy surrounding this landmark case, and consider what this means for clinical toxicology and patient safety. Hope you enjoy! Links to the papers we discussed: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69255-6/abstract https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00245-X/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140673608612544/abstract https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.1882 Link to the New Yorker Article : https://www.newyorker.com/magazine/2026/02/02/did-a-celebrated-researcher-obscure-a-fatal-poisoning Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us here: https://buymeacoffee.com/thetoxlab

  • April 13 · 29 min

    Episode 73: Pesticides – Flowers, Food and Forensics

    This week on The Tox Lab, we’re examining pesticides and their role in toxicology. We begin by discussing a study investigating pesticide exposure in florists, highlighting occupational risks and the potential for chronic low-level exposure. We then turn to a paper analysing pesticide residue levels in commonly consumed fruits, including kiwifruit and bananas, and consider what this may mean for dietary exposure. Finally, we discuss a study examining pesticide-related fatalities in Turkey, exploring the clinical and toxicological features associated with these cases. Join us as we explore the occupational, environmental, and clinical aspects of pesticide exposure, and consider what these findings mean for toxicology and public health. Hope you enjoy! Links to the papers we discussed: https://pmc.ncbi.nlm.nih.gov/articles/PMC5451977/ https://www.sciencedirect.com/science/article/abs/pii/S0273230026000103?via%3Dihub https://link.springer.com/article/10.1007/s12024-026-01220-x Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com Support us on: https://buymeacoffee.com/thetoxlab

  • S1 · E72
    April 6 · 23 min

    Episode 72: GHB – Forensic Toxicology, Detection and Interpretation (Part 2)

    This week on The Tox Lab, we continue our discussion on GHB, focusing on its role in forensic toxicology. We begin by examining a study investigating GHB in drug‑facilitated crime in Paris, highlighting patterns of reported incidents and toxicological findings. We then turn to post‑mortem toxicology, discussing the challenges of interpreting GHB concentrations after death and exploring research aimed at distinguishing post‑mortem formation from exogenous intake. Join us as we explore the forensic applications, interpretive challenges, and analytical considerations associated with GHB, and consider how these factors impact casework. This is part two of a two‑part series on GHB. In last week’s episode, we explored patterns of use, harms, and user perspectives. Hope you enjoy! Links to the papers we discussed: https://www.sciencedirect.com/science/article/abs/pii/S0379073825003780?via%3Dihub https://www.sciencedirect.com/science/article/pii/S2589871X24000925?via%3Dihub https://www.sciencedirect.com/science/article/pii/S0379073825001306?via%3Dihub Disclaimer: All opinions are our own. Find us on instagram: @the_tox_lab Email us here: thetoxlab@gmail.com

Showing 21–31 of 31 episodes